Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future
Oppenheimer Maintains Chemed(CHE.US) With Buy Rating, Maintains Target Price $650
Oppenheimer Sticks to Its Buy Rating for Chemed (CHE)
These Are the Mid-caps That Could Perform Best During 'Downturn' Regimes – BofA
Press Release: Chemed To Report Third-Quarter 2024 Earnings October 29, Related Conference Call To Be Held On October 30
Here's Why Chemed Corporation (CHE) Declined in Q2
Chemed Corporation's (NYSE:CHE) Shareholders Might Be Looking For Exit
Is Chemed Corporation's (NYSE:CHE) Recent Stock Performance Influenced By Its Financials In Any Way?
Looking Into Chemed's Recent Short Interest
Chemed Insider Sold Shares Worth $474,925, According to a Recent SEC Filing
Here's Why Chemed (CHE) Is a Strong Growth Stock
Have Chemed Insiders Been Selling Stock?
Chemed Insider Sold Shares Worth $2,781,897, According to a Recent SEC Filing
Insider Sale: Vice President Thomas Hutton Sells Shares of Chemed Corp (CHE)
Insider Sale: Executive Vice President Spencer Lee Sells Shares of Chemed Corp (CHE)
Stocks Ex-Dividend August 12
Recent Dividend Declarations
Chemed To Go Ex-Dividend On August 12th, 2024 With 0.5 USD Dividend Per Share
Press Release: Chemed Corporation Declares Quarterly Dividend of 50 Cents
Insider Sale: Executive Vice President Nicholas Westfall Sells Shares of Chemed Corp (CHE)